Global Fat Reduction Market - Industry Trends and Forecast to 2030
- Published Date: 2023-08-18
- Report ID: 145541
- Pages: 250
-
Format:
The global fat reduction market is expected to reach USD 28,817.02 million by 2033 from USD 10,748.45 million in 2022, growing at a CAGR of 9.5% during the forecast period of 2023 to 2033.
Market Segmentation:
Global Fat Reduction Market, By Type (Surgical Fat Reduction, Non-Invasive Fat Reduction, and Minimally Invasive), Application (Abdominal Fat, Thighs Fat, Buttock Fat, Upper-Arm Fat, Facial Fat, and Knee Fat), Gender (Female, Male), Age Group (Adult, Geriatric, and Child), End-User (Hospitals, Multi-Specialty Clinics, Dermatology Centers, Medical Spas, and Beauty Centers), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors and Others), Country (U.S.,Canada, Mexico, Costa Rica, Dominican Republic, Panama, El Salvador, Guatemala, Honduras, Nicaragua, Germany, Turkey, Italy, Poland, Spain, Russia, France, Netherlands, Switzerland, Belgium, Austria, Norway, Ireland, Hungary, Lithuania, Azerbaijan, U.K., Georgia, Ukraine, Rest of Europe, Japan India, China, South Korea, Thailand, Malaysia, Singapore, Australia, Philippines, Taiwan, Indonesia, New Zealand, Vietnam, Pakistan, Uzbekistan, Myanmar, Nepal, Cambodia, Rest of Asia-Pacific, Brazil, Argentina , Colombia, Chile, Peru, Ecuador, Bolivia, Paraguay, Rest of South America, Saudi Arabia, Egypt,UAE,South Africa, Israel, Kuwait, Qatar, Oman, Bahrain, Lebanon, Algeria, Jordan, Morocco, Iran, Libya, Iraq, Tunisia, Rest of Middle East and Africa) - Industry Trends and Forecast to 2033
Overview of Global Fat Reduction Market Dynamics:
Driver
Increasing demand for minimally invasive and non-invasive procedures
Restrain
High cost of procedures
Opportunity
Customized treatment plans and integration with other aesthetic procedures
Market Players:
The key market players operating in the global fat reduction market are listed below:
AbbVie Inc.
Cynosure
Alma Lasers
Candela Corporation
Merz Pharma
Solta Medical (Subsidiary of Bausch & Lomb Incorporated)
Cutera
MicroAire Surgical Instruments, LLC.
Others
TABLE OF CONTENTS
1 INTRODUCTION 227
1.1 OBJECTIVES OF THE STUDY 227
1.2 MARKET DEFINITION 227
1.3 OVERVIEW OF THE GLOBAL FAT REDUCTION MARKET 227
1.4 CURRENCY AND PRICING 229
1.5 LIMITATIONS 229
1.6 MARKETS COVERED 230
2 MARKET SEGMENTATION 235
2.1 MARKETS COVERED 235
2.2 GEOGRAPHICAL SCOPE 236
2.3 YEARS CONSIDERED FOR THE STUDY 237
2.4 DBMR TRIPOD DATA VALIDATION MODEL 238
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 241
2.6 MULTIVARIATE MODELLING 242
2.7 TYPE LIFELINE CURVE 242
2.8 DBMR MARKET POSITION GRID 243
2.9 VENDOR SHARE ANALYSIS 244
2.10 MARKET APPLICATION COVERAGE GRID 245
2.11 SECONDARY SOURCES 246
2.12 ASSUMPTIONS 246
3 EXECUTIVE SUMMARY 247
4 PREMIUM INSIGHT 251
4.1 PESTEL ANALYSIS 253
4.2 PORTERS FIVE FORCES 254
4.3 MARKET ANALYSIS 255
4.4 NORTH AMERICA (PRICING AND PROCEDURE ANALYSIS) 256
4.4.1 U.S. 256
4.4.2 CANADA 257
4.4.3 MEXICO 258
4.4.4 COSTA RICA 259
4.4.5 DOMINICIAN REPUBLIC 260
4.4.6 PANAMA 261
4.4.7 EL SALVADOR 262
4.4.8 GAUTEMALA 263
4.4.9 HONDURAS 264
4.4.10 NICARAGUA 265
4.5 EUROPE (PRICING AND PROCEDURE ANALYSIS) 266
4.5.1 GERMANY 266
4.5.2 TURKEY 267
4.5.3 ITALY 268
4.5.4 POLAND 269
4.5.5 SPAIN 270
4.5.6 RUSSIA 271
4.5.7 FRANCE 272
4.5.8 NETHERLANDS 273
4.5.9 SWITZERLAND 274
4.5.10 BELIGUM 275
4.5.11 AUSTRIA 276
4.5.12 NORWAY 277
4.5.13 IRELAND 278
4.5.14 HUNGARY 279
4.5.15 LITHUAMIA 280
4.5.16 AZERBAIJAN 281
4.5.17 U.K. 282
4.5.18 GEORGIA 283
4.5.19 UKRAINE 284
4.6 ASIA PACIFIC (PRICING AND PROCEDURE ANALYSIS) 285
4.6.1 JAPAN 285
4.6.2 INDIA 286
4.6.3 CHINA 287
4.6.4 SOUTH KOREA 288
4.6.5 THAILAND 289
4.6.6 MALAYSIA 290
4.6.7 SINGAPORE 291
4.6.8 AUSTRALIA 292
4.6.9 PHILIPPINES 293
4.6.10 TAIWAN 294
4.6.11 INDONESIA 295
4.6.12 NEW ZEALAND 296
4.6.13 VIETNAM 297
4.6.14 PAKISTAN 298
4.6.15 UZBEKISTAN 299
4.6.16 MYANMAR 300
4.6.17 NEPAL 301
4.6.18 COMBODIA 302
4.7 MIDDLE EAST & AFRICA (PRICING AND PROCEDURE ANALYSIS) 303
4.7.1 SAUDI ARABIA 303
4.7.2 EGYPT 304
4.7.3 UAE 305
4.7.4 SOUTH AFRICA 306
4.7.5 ISRAEL 307
4.7.6 KUWAIT 308
4.7.7 QATAR 309
4.7.8 OMAN 310
4.7.9 BAHRAIN 311
4.7.10 LEBANON 312
4.7.11 ALGERIA 313
4.7.12 JORDAN 314
4.7.13 MOROCCO 315
4.7.14 IRAN 316
4.7.15 LIBIYA 317
4.7.16 IRAQ 318
4.7.17 TUNISIA 319
4.8 SOUTH AMERICA (PRICING AND PROCEDURE ANALYSIS) 320
4.8.1 BRAZIL 320
4.8.2 ARGENTINA 321
4.8.3 COLOMBIA 322
4.8.4 CHILE 323
4.8.5 PERU 324
4.8.6 EQUADOR 325
4.8.7 BOLIVIA 326
4.8.8 PARAGUAY 327
4.9 BRAND ANALYSIS 328
4.9.1 KYBELLA 328
4.9.2 AQUALYX 329
4.10 PRICING ANALYSIS (USD) 330
4.10.1 NORTH AMERICA 330
4.10.1.1 U.S. 330
4.10.1.2 CANADA 330
4.10.1.3 MEXICO 330
4.10.1.4 COSTA RICA 331
4.10.1.5 DOMINICIAN REPUBLIC 331
4.10.1.6 PANAMA 331
4.10.1.7 EL SALVADOR 332
4.10.1.8 GAUTEMALA 332
4.10.1.9 HONDURAS 332
4.10.1.10 NICARAGUA 333
4.10.2 EUROPE 334
4.10.2.1 GERMANY 334
4.10.2.2 TURKEY 334
4.10.2.3 ITALY 334
4.10.2.4 POLAND 335
4.10.2.5 SPAIN 335
4.10.2.6 RUSSIA 335
4.10.2.7 FRANCE 336
4.10.2.8 NETHERLANDS 336
4.10.2.9 SWITZERLAND 336
4.10.2.10 BELIGUM 337
4.10.2.11 AUSTRIA 337
4.10.2.12 NORWAY 337
4.10.2.13 IRELAND 338
4.10.2.14 HUNGARY 338
4.10.2.15 LITHUAMIA 338
4.10.2.16 AZERBAIJAN 339
4.10.2.17 U.K. 339
4.10.2.18 GEORGIA 339
4.10.2.19 UKRAINE 340
4.10.3 ASIA-PACIFIC 341
4.10.3.1 JAPAN 341
4.10.3.2 INDIA 341
4.10.3.3 CHINA 341
4.10.3.4 SOUTH KOREA 342
4.10.3.5 THAILAND 342
4.10.3.6 MALAYSIA 342
4.10.3.7 SINGAPORE 343
4.10.3.8 AUSTRALIA 343
4.10.3.9 PHILIPPINES 343
4.10.3.10 TAIWAN 344
4.10.3.11 INDONESIA 344
4.10.3.12 NEW ZEALAND 344
4.10.3.13 VIETNAM 345
4.10.3.14 PAKISTAN 345
4.10.3.15 UZBEKISTAN 345
4.10.3.16 MYANMAR 346
4.10.3.17 NEPAL 346
4.10.3.18 COMBODIA 346
4.10.4 SOUTH AMERICA 347
4.10.4.1 BRAZIL 347
4.10.4.2 ARGENTINA 347
4.10.4.3 COLOMBIA 347
4.10.4.4 CHILE 348
4.10.4.5 PERU 348
4.10.4.6 EQUADOR 348
4.10.4.7 BOLIVIA 349
4.10.4.8 PARAGUAY 349
4.10.5 MIDDLE EAST & AFRICA 350
4.10.5.1 SAUDI ARABIA 350
4.10.5.2 EGYPT 350
4.10.5.3 UAE 350
4.10.5.4 SOUTH AFRICA 351
4.10.5.5 ISRAEL 351
4.10.5.6 KUWAIT 351
4.10.5.7 QATAR 352
4.10.5.8 OMAN 352
4.10.5.9 BAHRAIN 352
4.10.5.10 LEBANON 352
4.10.5.11 ALGERIA 353
4.10.5.12 JORDAN 353
4.10.5.13 MOROCCO 353
4.10.5.14 IRAN 353
4.10.5.15 LIBIYA 354
4.10.5.16 IRAQ 354
4.10.5.17 TUNISIA 354
4.11 PATENT ANALYSIS OF THE GLOBAL FAT REDUCTION MARKET 355
4.11.1 U.S. 355
4.11.1.1 METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID 355
4.11.1.2 COMPOSITIONS COMPRISING DEOXYCHOLIC ACID AND SALTS THEREOF SUITABLE FOR USE IN TREATING EAT DEPOSITS 356
4.11.1.3 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 357
4.11.1.4 SYNTHETIC BILE ACID COMPOSITIONS AND METHODS 357
4.11.2 CANADA 358
4.11.2.1 SYNTHETIC BILE ACID COMPOSITIONS AND METHODS 358
4.11.2.2 BELKYRA 358
4.11.2.3 BELKYRA 359
4.11.2.4 BELKYRA 359
4.11.3 MEXICO 360
4.11.3.1 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF. 360
4.11.3.2 TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF. 360
4.11.4 EUROPE 361
4.11.4.1 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 361
4.11.4.2 SYNTHESIS OF DEOXYCHOLIC ACID (DCA) 362
4.11.4.3 METHOD AND COMPOSITION FOR REDUCING SUBCUTANEOUS FAT 363
4.11.4.4 METHOD AND COMPOSITION FOR REDUCING SUBCUTANEOUS FAT DEPOSITS 364
4.11.5 HUNGARY 365
4.11.5.1 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 365
4.11.6 JAPAN 365
4.11.6.1 FORMULATION OF DEOXYCHOLIC ACID AND ITS SALTS 365
4.11.6.2 METHOD FOR TREATING ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND ITS SALTS 366
4.11.6.3 FORMULATION OF DEOXYCHOLIC ACID AND ITS SALTS 366
4.11.6.4 FORMULATION OF DEOXYCHOLIC ACID AND ITS SALTS 367
4.11.7 AUSTRALIA 367
4.11.7.1 TREATMENTS OF ACCUMULATED FAT WITH DEOXYCHOLIC ACID AND SALTS THEREOF 367
4.11.7.2 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 368
4.11.8 CHINA 369
4.11.8.1 THE PREPARATION OF DEOXYCHOLIC ACID AND ITS SALT 369
4.11.8.2 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 369
4.11.8.3 TREATMENT USING DEOXYCHOLIC ACID AND ITS SALT TO THE FAT OF ACCUMULATION 370
4.11.9 SOUTH AFRICA 371
4.11.9.1 FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF 371
4.11.10 INDIA 371
4.11.11 SOUTH KOREA 371
4.12 PRICING ANALYSIS (USD) 373
4.12.1 KYBELLA 373
4.12.2 COOLSCULPTING 375
4.12.3 COOLSCULPTING ELITE 377
4.12.4 COOLTONE 379
5 INDUSTRY INSIGHTS: 382
5.1 DEMOGRAPHIC TRENDS: 383
5.2 CONCLUSION: 384
6 GLOBAL FAT REDUCTION MARKET, REGULATIONS 385
6.1 U.S. 385
6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE: 385
6.1.2 POST-MARKETING SURVEILLANCE: 387
6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES: 387
6.2 CANADA 388
6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 388
6.2.2 LICENSING AND REGISTRATION 389
6.2.3 POST EXPIRY OF PATENT REGIME 389
6.2.4 POST-MARKETING SURVEILLANCE 389
6.3 MEXICO 390
6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 390
6.3.2 REGULATORY APPROVAL AGENCIES 390
6.3.3 LICENSING AND REGISTRATION 391
6.3.4 POST-MARKETING SURVEILLANCE 391
6.4 DOMINICAN REPUBLIC 391
6.4.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 391
6.4.2 RENEWAL OF REGISTRATION IS REQUIRED IF THERE IS A CHANGE IN PRODUCT FORMULATION OR A CHANGE IN THE SITE OF MANUFACTURE. 392
6.4.3 TIMELINE 393
6.5 GUATEMALA 393
6.5.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 393
6.5.2 REGULATORY APPROVAL AGENCIES 393
6.5.3 LICENSING AND REGISTRATION 394
6.5.4 POST-MARKETING SURVEILLANCE 394
6.5.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES 394
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
